They had zero financing . Zero clinical trials. And about 60 million less Outstanding. And the share price today is 40 cents below that of 2012. Lol.
Now we have millions in the bank - millions available and 8 SUCCESSFUL clinical trials. Not to mention the B franchise. And we are trading much lower. If that does not scream buying opportunity.......I’m not sure you should be in the market.